<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="347844">
  <stage>Registered</stage>
  <submitdate>12/08/2012</submitdate>
  <approvaldate>22/08/2012</approvaldate>
  <actrnumber>ACTRN12612000892819</actrnumber>
  <trial_identification>
    <studytitle>Dexmedetomidine pharmacodynamics and population pharmacokinetics in elderly  intensive care unit (ICU) patients</studytitle>
    <scientifictitle>Dexmedetomidine pharmacodynamics and population pharmacokinetics in elderly Intensive Care Unit (ICU) patients aged 65 and above.</scientifictitle>
    <utrn>U1111-1126-3682</utrn>
    <trialacronym />
    <secondaryid>None</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Intensive Care patients aged 65 and more</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Anaesthetics</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Eligible patients will be administered 0.2 to 0.5 mcg/kg/hr intravenous dexmedetomidine to  achieve RASS score of 0 to -2. Pharmacodynamic parameters monitored are the RASS score, heart rate, blood pressure, respiratory rate, temperature. Sparse blood samples will be taken to measure serum dexmedetomidine levels, where the population pharmacokinetics will be studied.

The pharmacodynamic parameters will be continuous  for 48 hours, and the blood sampling will occur six times over 48 hours.</interventions>
    <comparator>Nil</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Optimal dose of dexmedetomidine in elderly patients in a Malaysian Intensive Care Unit will be assessed clinically with the RASS (Richmond Agitation Sedation Scale), mean arterial pressure and heart rate.</outcome>
      <timepoint>After completion of data collection</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Population pharmacokinetics will be determined with serum samples taken at different intervals during dexmedetomidine infusion, and analysed via chromatography. Data collected will be analysed via NONMEM.</outcome>
      <timepoint>After completion of data collection</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Intensive Care Unit  (ICU) patients at the University of Malaya Medical Centre (UMMC) requiring invasive ventilation and sedation of at least 48 hours duration</inclusivecriteria>
    <inclusiveminage>65</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>1. Patient or relative refusal
2. Previous adverse reaction to alpha2 agonists
3. Second degree or higher heart blocks
4. Liver failure
5. Kidney failure requiring renal replacement therapy</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment>ICU physician in charged of an eligible subject determines the indication of sedation. After ruling out the exclusion criteria, consent is obtained.</concealment>
    <sequence>Not applicable</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint>Pharmacokinetics / pharmacodynamics</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>8/11/2011</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>60</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Malaysia</country>
      <state>Kuala Lumpur</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Noorjahan Haneem binti Md Hashim</primarysponsorname>
    <primarysponsoraddress>Department of Anaesthesiology,
Faculty of Medicine,
University of Malaya,
50603 Kuala Lumpur</primarysponsoraddress>
    <primarysponsorcountry>Malaysia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>University of Malaya</fundingname>
      <fundingaddress>University of Malaya
50603 Kuala Lumpur</fundingaddress>
      <fundingcountry>Malaysia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Lucy Chan</sponsorname>
      <sponsoraddress>Department of Anaesthesiology,
Faculty of Medicine,
University of Malaya,
50603 Kuala Lumpur</sponsoraddress>
      <sponsorcountry>Malaysia</sponsorcountry>
    </secondarysponsor>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Gracie Ong Siok Yan</sponsorname>
      <sponsoraddress>Department of Anaesthesiology,
Faculty of Medicine,
University of Malaya,
50603 Kuala Lumpur</sponsoraddress>
      <sponsorcountry>Malaysia</sponsorcountry>
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Wong Kang Kwong</othercollaboratorname>
      <othercollaboratoraddress>Department of Anaesthesiology,
Faculty of Medicine,
University of Malaya,
50603 Kuala Lumpur</othercollaboratoraddress>
      <othercollaboratorcountry>Malaysia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Suresh Venugobal</othercollaboratorname>
      <othercollaboratoraddress>Department of Anaesthesiology,
Faculty of Medicine,
University of Malaya,
50603 Kuala Lumpur</othercollaboratoraddress>
      <othercollaboratorcountry>Malaysia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Mohd Shahnaz Hasan</othercollaboratorname>
      <othercollaboratoraddress>Department of Anaesthesiology,
Faculty of Medicine,
University of Malaya,
50603 Kuala Lumpur</othercollaboratoraddress>
      <othercollaboratorcountry>Malaysia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Vineya Rai Hakumat Rai</othercollaboratorname>
      <othercollaboratoraddress>Department of Anaesthesiology,
Faculty of Medicine,
University of Malaya,
50603 Kuala Lumpur</othercollaboratoraddress>
      <othercollaboratorcountry>Malaysia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Mustafa Ali Mohd</othercollaboratorname>
      <othercollaboratoraddress>SUCXeS Laboratory,
Department of Pharmacology
Faculty of Medicine,
University of Malaya,
50603 Kuala Lumpur</othercollaboratoraddress>
      <othercollaboratorcountry>Malaysia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Lee Toong Chow</othercollaboratorname>
      <othercollaboratoraddress>Dean's Office,
Faculty of Medicine,
University of Malaya,
50603 Kuala Lumpur</othercollaboratoraddress>
      <othercollaboratorcountry>Malaysia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Dexmedetomidine is a sedation medication used daily in our ICU. Though the manufacturer and literature recommends a lower dose for patient above 65 years old, the dose is yet not known. We aim to find out the best dose to be used in patients 65 years and above in our ICU, and to recommend the dose for similar patients in the whole country.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>University of Malaya Medical Centre Ethics Committee</ethicname>
      <ethicaddress>University of Malaya Medical Centre
50603 Kuala Lumpur</ethicaddress>
      <ethicapprovaldate>1/07/2011</ethicapprovaldate>
      <hrec>1/07/0859</hrec>
      <ethicsubmitdate>8/06/2011</ethicsubmitdate>
      <ethiccountry>Malaysia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Noorjahan Haneem binti Md Hashim</name>
      <address>Department of Anaesthesiology, 
Faculty of Medicine,
University of Malaya,
50603 Kuala Lumpur</address>
      <phone>+60379492052</phone>
      <fax>+0379556705</fax>
      <email>noorjahan@ummc.edu.my</email>
      <country>Malaysia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Noorjahan Haneem binti Md Hashim</name>
      <address>Department of Anaesthesiology, 
Faculty of Medicine,
University of Malaya,
50603 Kuala Lumpur</address>
      <phone>+60379492052</phone>
      <fax>+60379556705</fax>
      <email>noorjahan@ummc.edu.my</email>
      <country>Malaysia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Noorjahan Haneem binti Md Hashim</name>
      <address>Department of Anaesthesiology, 
Faculty of Medicine,
University of Malaya,
50603 Kuala Lumpur</address>
      <phone>+60379492052</phone>
      <fax>+60379556705</fax>
      <email>noorjahan@ummc.edu.my</email>
      <country>Malaysia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>